Sector revisions Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 09:15:47 2026-02-17 EST			5-day change	1st Jan Change
310.10 ^DKK	+0.80%		-1.46%	-4.58%

09:06am	EU approves higher dose of Novo's Wegovy	RE
09:01am	European Commission approves more effective dose of Novo Nordisk's injectable Wegovy for adults	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	NOVO NORDISK A/S							22
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							24
	ABBVIE INC.							27
	ROCHE HOLDING AG							20
	ASTRAZENECA PLC							21
	NOVARTIS AG							21
	MERCK & CO., INC.							26
	AMGEN INC.							27
	GILEAD SCIENCES, INC.							26
	PFIZER INC.							24
	VERTEX PHARMACEUTICALS INCORPORATED							26
	BRISTOL-MYERS SQUIBB COMPANY							23
	GSK PLC							20
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	BAYER AG							20
	Average							22
	Weighted average by Cap.							24